Cloforex

Summary

Cloforex (CHEMBL1697686) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 255.74 Da · C13H18ClNO2

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1697686
Name	Cloforex
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	26602
Molecular formula	C13H18ClNO2
Molecular weight	255.74
InChIKey	TZWKUQDQKPYNLL-UHFFFAOYSA-N

SMILES: CCOC(=O)NC(C)(C)CC1=CC=C(C=C1)Cl

IUPAC name: ethyl N-[1-(4-chlorophenyl)-2-methylpropan-2-yl]carbamate

Also known as: Cloforex, D 237, D-237, SID144206822, CLOFOREX, cloforex

Patent coverage: 451 distinct patent families (2,065 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).